|
gptkbp:instanceOf
|
person
|
|
gptkbp:affiliation
|
gptkb:Moderna,_Inc.
|
|
gptkbp:almaMater
|
gptkb:École_Centrale_Paris
|
|
gptkbp:awards
|
nan
|
|
gptkbp:birthPlace
|
Marseille,_France
|
|
gptkbp:challenges
|
vaccine distribution
|
|
gptkbp:children
|
nan
|
|
gptkbp:collaborations
|
various pharmaceutical companies
|
|
gptkbp:contribution
|
mRNA vaccines
|
|
gptkbp:education
|
gptkb:Harvard_Business_School
|
|
gptkbp:field
|
biotechnology
|
|
gptkbp:futurePlans
|
new vaccine technologies
expand vaccine access
|
|
gptkbp:hasLanguage
|
English
French
nan
|
|
gptkbp:hasMember
|
nan
|
|
gptkbp:hobbies
|
running
reading
traveling
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Stéphane Bancel
|
|
gptkbp:impact
|
global health
|
|
gptkbp:influences
|
mRNA technology
|
|
gptkbp:inspiration
|
scientific innovation
|
|
gptkbp:involved
|
COVID-19 response
|
|
gptkbp:knownFor
|
gptkb:Moderna
COVID-19 vaccine development
|
|
gptkbp:lawEnforcement
|
gptkb:United_States
|
|
gptkbp:leadership
|
gptkb:Moderna
collaborative
|
|
gptkbp:mediaAppearances
|
interviews on vaccine development
|
|
gptkbp:nationality
|
French
|
|
gptkbp:network
|
biotech industry
|
|
gptkbp:nextStation
|
CEO of BioMérieux
|
|
gptkbp:occupation
|
CEO
|
|
gptkbp:patentCitation
|
nan
|
|
gptkbp:personalLife
|
private
|
|
gptkbp:philanthropy
|
health initiatives
|
|
gptkbp:publicSpeaking
|
health conferences
|
|
gptkbp:researchField
|
vaccine development
|
|
gptkbp:researchInterest
|
infectious diseases
|
|
gptkbp:residence
|
gptkb:Cambridge,_Massachusetts
|
|
gptkbp:spouse
|
nan
|
|
gptkbp:strategicGoals
|
public health
|
|
gptkbp:succeededBy
|
rapid vaccine development
|
|
gptkbp:title
|
CEO_of_Moderna
|
|
gptkbp:vision
|
advancing mRNA technology
|
|
gptkbp:yearsActive
|
2000-present
|